These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30785932)

  • 21. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes.
    Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M
    Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection.
    Khanna S; Montassier E; Schmidt B; Patel R; Knights D; Pardi DS; Kashyap P
    Aliment Pharmacol Ther; 2016 Oct; 44(7):715-727. PubMed ID: 27481036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection.
    Herrera G; Vega L; Patarroyo MA; Ramírez JD; Muñoz M
    Sci Rep; 2021 May; 11(1):10849. PubMed ID: 34035404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study.
    Milani C; Ticinesi A; Gerritsen J; Nouvenne A; Lugli GA; Mancabelli L; Turroni F; Duranti S; Mangifesta M; Viappiani A; Ferrario C; Maggio M; Lauretani F; De Vos W; van Sinderen D; Meschi T; Ventura M
    Sci Rep; 2016 May; 6():25945. PubMed ID: 27166072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home.
    Rodriguez C; Taminiau B; Korsak N; Avesani V; Van Broeck J; Brach P; Delmée M; Daube G
    BMC Microbiol; 2016 Oct; 16(1):229. PubMed ID: 27716140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences of the Fecal Microflora With Clostridium difficile Therapies.
    Louie TJ; Byrne B; Emery J; Ward L; Krulicki W; Nguyen D; Wu K; Cannon K
    Clin Infect Dis; 2015 May; 60 Suppl 2():S91-7. PubMed ID: 25922407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disordered Intestinal Microbial Communities During
    Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
    Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.
    Zhou Y; Mao L; Yu J; Lin Q; Luo Y; Zhu X; Sun Z
    BMC Infect Dis; 2019 Mar; 19(1):232. PubMed ID: 30845918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study.
    Solbach P; Chhatwal P; Woltemate S; Tacconelli E; Buhl M; Autenrieth IB; Vehreschild MJGT; Jazmati N; Gerhard M; Stein-Thoeringer CK; Rupp J; Ulm K; Ott A; Lasch F; Koch A; Manns MP; Suerbaum S; Bachmann O
    Clin Infect Dis; 2021 Nov; 73(9):e2625-e2634. PubMed ID: 32589701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M; Szczegielniak A; Wiechuła B; Harmanus C; Kuijper E; Martirosian G
    Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population.
    Gu S; Chen Y; Zhang X; Lu H; Lv T; Shen P; Lv L; Zheng B; Jiang X; Li L
    Microbes Infect; 2016 Jan; 18(1):30-8. PubMed ID: 26383014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease.
    Roy Chowdhury P; DeMaere M; Chapman T; Worden P; Charles IG; Darling AE; Djordjevic SP
    BMC Microbiol; 2016 Mar; 16():41. PubMed ID: 26971047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
    Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
    PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic
    Han SH; Yi J; Kim JH; Moon AH
    Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32545219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya.
    Oyaro MO; Plants-Paris K; Bishoff D; Malonza P; Gontier CS; DuPont HL; Darkoh C
    Int J Infect Dis; 2018 Sep; 74():24-28. PubMed ID: 29960098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.
    Allegretti JR; Kearney S; Li N; Bogart E; Bullock K; Gerber GK; Bry L; Clish CB; Alm E; Korzenik JR
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1142-53. PubMed ID: 27086647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with
    Džunková M; D'Auria G; Xu H; Huang J; Duan Y; Moya A; Kelly CP; Chen X
    Front Cell Infect Microbiol; 2016; 6():119. PubMed ID: 27757389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.